Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108. (Q33423638)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108. |
scientific article |
Statements
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108 (English)
Steven M Horwitz
Hongli Li
Catherine Spier
Daruka Mahadevan
Michael LeBlanc
Mansoor Ul Haq
Bryan D Huber
Christopher R Flowers
Nina D Wagner-Johnston
Richard I Fisher
Sonali M Smith
Brad S Kahl
Jonathan W Friedberg
15 June 2015